rendering of a globe and news stories

PPD in the News

Regulatory Rapporteur (June 2021)

Preparing for data transparency requirements of the new EU CTR

The authors discuss some steps organizations must take now to ensure readiness for the application of the EU Clinical Trial Regulation.

regulatory rapporteur logo
Genetic Engineering & Biotechnology News (June 2021)

Good CROs Make Dream Teams, Great CROs Make Dynasties

Elisha Talley-Roithner outlines some of the reasons for considering outsourcing opportunities with CROs.

BioPharm International (June 2021)

Development strategies for cell and gene therapy methods

The authors discuss how the increase in regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.

biopharm logo
Contract Pharma (June 2021)

CRO industry update

PPD’s Les Enterline explains that COVID-19 has accelerated the need for clients to have rapid access to additional highly trained professionals to support their pipelines in what already was a highly competitive market.

contract pharma logo
Fierce Biotech (June 2021)

PPD cuts the ribbon on new clinical research lab in Suzhou, China

PPD held a grand opening ceremony for its new multipurpose laboratory in Suzhou, China, to support Western and China-based pharmaceutical and biotech companies managing China research studies.

Fierce Biotech
Greater Wilmington Business Journal (May 2021)

PPD opens clinical research lab in Suzhou, China

The 67,000-square-foot facility offers bioanalytical, biomarker and vaccine laboratory services to support trials across all phases of pharmaceutical development.

greater wilmington business journal logo
BioPharma-Reporter (May 2021)

PPD adds cell and gene therapy testing capabilities to Irish site

PPD is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing.

Fierce Biotech (April 2021)

PPD sees major sales jump for its last financial update, as Thermo Fisher begins buyout

PPD reports its first quarter 2021 financial results.

Fierce Biotech
Fierce Biotech (April 2021)

PPD doubles down on Science 37 collab for siteless trial push

PPD and Science 37 announced an innovative collaboration in which PPD will be fully enabled to design, build, test, implement and execute digital trials using Science 37's DCT platform.

Fierce Biotech